Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fde54ae1658-trace').style.display = (document.getElementById('cakeErr67fde54ae1658-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fde54ae1658-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fde54ae1658-code').style.display = (document.getElementById('cakeErr67fde54ae1658-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fde54ae1658-context').style.display = (document.getElementById('cakeErr67fde54ae1658-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fde54ae1658-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fde54ae1658-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 7812,
		&#039;title&#039; =&gt; &#039;Details of patented drugs to be made public by CH Unnikrishnan&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;
&lt;br /&gt;
Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;
&lt;br /&gt;
Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;
&lt;br /&gt;
The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;
&lt;br /&gt;
India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;
&lt;br /&gt;
The companies involved had denied any wrongdoing.&lt;br /&gt;
&lt;br /&gt;
The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;
&lt;br /&gt;
Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Live Mint, 23 May, 2011, http://www.livemint.com/2011/05/23002205/Details-of-patented-drugs-to-b.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 7911,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 7812,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;&lt;br /&gt;Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;&lt;br /&gt;Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;&lt;br /&gt;The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;&lt;br /&gt;India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;&lt;br /&gt;An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;&lt;br /&gt;The companies involved had denied any wrongdoing.&lt;br /&gt;&lt;br /&gt;The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;&lt;br /&gt;Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 7812,
	&#039;title&#039; =&gt; &#039;Details of patented drugs to be made public by CH Unnikrishnan&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;
&lt;br /&gt;
Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;
&lt;br /&gt;
Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;
&lt;br /&gt;
The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;
&lt;br /&gt;
India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;
&lt;br /&gt;
The companies involved had denied any wrongdoing.&lt;br /&gt;
&lt;br /&gt;
The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;
&lt;br /&gt;
Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Live Mint, 23 May, 2011, http://www.livemint.com/2011/05/23002205/Details-of-patented-drugs-to-b.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 7911,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 7812
$metaTitle = &#039;LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;&lt;br /&gt;Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;&lt;br /&gt;Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;&lt;br /&gt;The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;&lt;br /&gt;India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;&lt;br /&gt;An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;&lt;br /&gt;The companies involved had denied any wrongdoing.&lt;br /&gt;&lt;br /&gt;The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;&lt;br /&gt;Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan | Im4change.org</title>
    <meta name="description" content="
To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Details of patented drugs to be made public by CH Unnikrishnan</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.<br /><br />Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.<br /><br />&ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&rdquo; P.H. Kurian, India&rsquo;s controller general of patents, designs and trademarks, said on Friday.<br /><br />Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.<br /><br />&ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.<br /><br />The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.<br /><br />India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.<br /><br />&ldquo;It&rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.<br /><br />&ldquo;Making such information available to public through official websites or not is the discretion of the government,&rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&rdquo;<br /><br />An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.<br /><br />The companies involved had denied any wrongdoing.<br /><br />The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.<br /><br />Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fde54ae1658-trace').style.display = (document.getElementById('cakeErr67fde54ae1658-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fde54ae1658-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fde54ae1658-code').style.display = (document.getElementById('cakeErr67fde54ae1658-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fde54ae1658-context').style.display = (document.getElementById('cakeErr67fde54ae1658-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fde54ae1658-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fde54ae1658-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 7812,
		&#039;title&#039; =&gt; &#039;Details of patented drugs to be made public by CH Unnikrishnan&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;
&lt;br /&gt;
Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;
&lt;br /&gt;
Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;
&lt;br /&gt;
The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;
&lt;br /&gt;
India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;
&lt;br /&gt;
The companies involved had denied any wrongdoing.&lt;br /&gt;
&lt;br /&gt;
The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;
&lt;br /&gt;
Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Live Mint, 23 May, 2011, http://www.livemint.com/2011/05/23002205/Details-of-patented-drugs-to-b.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 7911,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 7812,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;&lt;br /&gt;Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;&lt;br /&gt;Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;&lt;br /&gt;The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;&lt;br /&gt;India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;&lt;br /&gt;An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;&lt;br /&gt;The companies involved had denied any wrongdoing.&lt;br /&gt;&lt;br /&gt;The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;&lt;br /&gt;Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 7812,
	&#039;title&#039; =&gt; &#039;Details of patented drugs to be made public by CH Unnikrishnan&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;
&lt;br /&gt;
Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;
&lt;br /&gt;
Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;
&lt;br /&gt;
The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;
&lt;br /&gt;
India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;
&lt;br /&gt;
The companies involved had denied any wrongdoing.&lt;br /&gt;
&lt;br /&gt;
The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;
&lt;br /&gt;
Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Live Mint, 23 May, 2011, http://www.livemint.com/2011/05/23002205/Details-of-patented-drugs-to-b.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 7911,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 7812
$metaTitle = &#039;LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;&lt;br /&gt;Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;&lt;br /&gt;Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;&lt;br /&gt;The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;&lt;br /&gt;India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;&lt;br /&gt;An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;&lt;br /&gt;The companies involved had denied any wrongdoing.&lt;br /&gt;&lt;br /&gt;The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;&lt;br /&gt;Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan | Im4change.org</title>
    <meta name="description" content="
To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Details of patented drugs to be made public by CH Unnikrishnan</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.<br /><br />Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.<br /><br />&ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&rdquo; P.H. Kurian, India&rsquo;s controller general of patents, designs and trademarks, said on Friday.<br /><br />Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.<br /><br />&ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.<br /><br />The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.<br /><br />India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.<br /><br />&ldquo;It&rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.<br /><br />&ldquo;Making such information available to public through official websites or not is the discretion of the government,&rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&rdquo;<br /><br />An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.<br /><br />The companies involved had denied any wrongdoing.<br /><br />The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.<br /><br />Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fde54ae1658-trace').style.display = (document.getElementById('cakeErr67fde54ae1658-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fde54ae1658-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fde54ae1658-code').style.display = (document.getElementById('cakeErr67fde54ae1658-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fde54ae1658-context').style.display = (document.getElementById('cakeErr67fde54ae1658-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fde54ae1658-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fde54ae1658-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 7812,
		&#039;title&#039; =&gt; &#039;Details of patented drugs to be made public by CH Unnikrishnan&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;
&lt;br /&gt;
Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;
&lt;br /&gt;
Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;
&lt;br /&gt;
The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;
&lt;br /&gt;
India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;
&lt;br /&gt;
The companies involved had denied any wrongdoing.&lt;br /&gt;
&lt;br /&gt;
The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;
&lt;br /&gt;
Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Live Mint, 23 May, 2011, http://www.livemint.com/2011/05/23002205/Details-of-patented-drugs-to-b.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 7911,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 7812,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;&lt;br /&gt;Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;&lt;br /&gt;Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;&lt;br /&gt;The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;&lt;br /&gt;India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;&lt;br /&gt;An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;&lt;br /&gt;The companies involved had denied any wrongdoing.&lt;br /&gt;&lt;br /&gt;The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;&lt;br /&gt;Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 7812,
	&#039;title&#039; =&gt; &#039;Details of patented drugs to be made public by CH Unnikrishnan&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;
&lt;br /&gt;
Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;
&lt;br /&gt;
Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;
&lt;br /&gt;
The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;
&lt;br /&gt;
India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;
&lt;br /&gt;
An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;
&lt;br /&gt;
The companies involved had denied any wrongdoing.&lt;br /&gt;
&lt;br /&gt;
The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;
&lt;br /&gt;
Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Live Mint, 23 May, 2011, http://www.livemint.com/2011/05/23002205/Details-of-patented-drugs-to-b.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 7911,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 7812
$metaTitle = &#039;LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;To increase transparency, India&amp;rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.&lt;br /&gt;&lt;br /&gt;Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&amp;rdquo; P.H. Kurian, India&amp;rsquo;s controller general of patents, designs and trademarks, said on Friday.&lt;br /&gt;&lt;br /&gt;Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&amp;rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.&lt;br /&gt;&lt;br /&gt;The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.&lt;br /&gt;&lt;br /&gt;India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&amp;rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;It&amp;rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&amp;rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Making such information available to public through official websites or not is the discretion of the government,&amp;rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &amp;ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&amp;rdquo;&lt;br /&gt;&lt;br /&gt;An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.&lt;br /&gt;&lt;br /&gt;The companies involved had denied any wrongdoing.&lt;br /&gt;&lt;br /&gt;The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.&lt;br /&gt;&lt;br /&gt;Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&amp;rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan | Im4change.org</title>
    <meta name="description" content="
To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Details of patented drugs to be made public by CH Unnikrishnan</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.<br /><br />Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.<br /><br />&ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&rdquo; P.H. Kurian, India&rsquo;s controller general of patents, designs and trademarks, said on Friday.<br /><br />Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.<br /><br />&ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.<br /><br />The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.<br /><br />India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.<br /><br />&ldquo;It&rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.<br /><br />&ldquo;Making such information available to public through official websites or not is the discretion of the government,&rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&rdquo;<br /><br />An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.<br /><br />The companies involved had denied any wrongdoing.<br /><br />The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.<br /><br />Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 7812,
		'title' => 'Details of patented drugs to be made public by CH Unnikrishnan',
		'subheading' => '',
		'description' => '<div align="justify">
To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.<br />
<br />
Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.<br />
<br />
&ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&rdquo; P.H. Kurian, India&rsquo;s controller general of patents, designs and trademarks, said on Friday.<br />
<br />
Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.<br />
<br />
&ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.<br />
<br />
The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.<br />
<br />
India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.<br />
<br />
&ldquo;It&rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.<br />
<br />
&ldquo;Making such information available to public through official websites or not is the discretion of the government,&rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&rdquo;<br />
<br />
An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.<br />
<br />
The companies involved had denied any wrongdoing.<br />
<br />
The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.<br />
<br />
Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.
</div>',
		'credit_writer' => 'Live Mint, 23 May, 2011, http://www.livemint.com/2011/05/23002205/Details-of-patented-drugs-to-b.html',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 7911,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 7812,
	'metaTitle' => 'LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan',
	'metaKeywords' => 'Health',
	'metaDesc' => '
To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the...',
	'disp' => '<div align="justify">To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.<br /><br />Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.<br /><br />&ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&rdquo; P.H. Kurian, India&rsquo;s controller general of patents, designs and trademarks, said on Friday.<br /><br />Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.<br /><br />&ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.<br /><br />The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.<br /><br />India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.<br /><br />&ldquo;It&rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.<br /><br />&ldquo;Making such information available to public through official websites or not is the discretion of the government,&rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&rdquo;<br /><br />An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.<br /><br />The companies involved had denied any wrongdoing.<br /><br />The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.<br /><br />Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 7812,
	'title' => 'Details of patented drugs to be made public by CH Unnikrishnan',
	'subheading' => '',
	'description' => '<div align="justify">
To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.<br />
<br />
Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.<br />
<br />
&ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&rdquo; P.H. Kurian, India&rsquo;s controller general of patents, designs and trademarks, said on Friday.<br />
<br />
Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.<br />
<br />
&ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.<br />
<br />
The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.<br />
<br />
India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.<br />
<br />
&ldquo;It&rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.<br />
<br />
&ldquo;Making such information available to public through official websites or not is the discretion of the government,&rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&rdquo;<br />
<br />
An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.<br />
<br />
The companies involved had denied any wrongdoing.<br />
<br />
The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.<br />
<br />
Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.
</div>',
	'credit_writer' => 'Live Mint, 23 May, 2011, http://www.livemint.com/2011/05/23002205/Details-of-patented-drugs-to-b.html',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'details-of-patented-drugs-to-be-made-public-by-ch-unnikrishnan-7911',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 7911,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 7812
$metaTitle = 'LATEST NEWS UPDATES | Details of patented drugs to be made public by CH Unnikrishnan'
$metaKeywords = 'Health'
$metaDesc = '
To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.

Patent holders in the country are required to submit once every year the...'
$disp = '<div align="justify">To increase transparency, India&rsquo;s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price.<br /><br />Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27.<br /><br />&ldquo;We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,&rdquo; P.H. Kurian, India&rsquo;s controller general of patents, designs and trademarks, said on Friday.<br /><br />Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April.<br /><br />&ldquo;Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,&rdquo; said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences.<br /><br />The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand.<br /><br />India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right&rsquo;s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market.<br /><br />&ldquo;It&rsquo;s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,&rdquo; said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers.<br /><br />&ldquo;Making such information available to public through official websites or not is the discretion of the government,&rdquo; said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. &ldquo;Even otherwise, it is available to the public through the RTI (Right to Information Act).&rdquo;<br /><br />An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally.<br /><br />The companies involved had denied any wrongdoing.<br /><br />The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection.<br /><br />Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India&rsquo;s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Details of patented drugs to be made public by CH Unnikrishnan

To increase transparency, India’s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price. Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has been met partly, adequately or to the fullest extent for a particular drug at a reasonable price in a statutory format called Form 27. “We will put all the details compiled from Form 27s filed by the patent holders on our website from June onwards,” P.H. Kurian, India’s controller general of patents, designs and trademarks, said on Friday. Many companies, which sell high-value drugs under patent protection, are lax in disclosing mandatory data about the working status of their patents in the local market, Mint reported on 7 April. “Since most of the patented drugs are costly and the access is a critical issue, it is very important for the public to have this information,” said Shamnad Basheer, a professor in intellectual property law at Kolkata-based National University of Juridical Sciences. The data on the working status of patents is also useful for companies capable of producing the same products in the local market because they can then apply for compulsory licences in case a patent holder is unable to meet domestic demand. India allows generic versions of some patented medicines to be produced and sold by third parties without the consent of the right’s owner to ensure availability of the drug at a reasonable price in case of public health emergencies and some other circumstances, such as a company abusing its dominant position in the market. “It’s an important move and will certainly help the generic industry to come up with compulsory licence applications based on the information, which is filed by patent holders themselves,” said Dilip G. Shah, secretary general of Indian Pharmaceutical Alliance, an industry lobby of local drug makers. “Making such information available to public through official websites or not is the discretion of the government,” said Tapan Ray, director general of Organisation of Pharmaceutical Producers of India, the lobby of foreign drug makers, which hold most patent rights on drugs in the local market. “Even otherwise, it is available to the public through the RTI (Right to Information Act).” An RTI disclosure in April had revealed that some large multinational drug makers, including Pfizer Inc., Bristol Myers Squibb Co., F. Hoffmann-La Roche AG, Bayer AG and Schering (currently owned by Merck and Co. Inc.), did not disclose all mandatory information about the working status of their patents and some filed the returns only occasionally. The companies involved had denied any wrongdoing. The RTI was filed by a group of lawyers, including Basheer, last year to access the information on seven life-saving drugs sold in India under patent protection. Failing to submit Form 27 and furnishing inadequate or wrong information are punishable offences under India’s Patents Act. It attracts a penalty of up to Rs. 10 lakh per patent.